tetano
Editor, Senior Moderator
Investigators publish new data in the report 'Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection.' According to a study from Zagreb, Croatia, "Guillain-Barre syndrome (GBS) is a well known entity that has many infectious agents reported as antecedent events. The spectrum of GBS includes acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), acute motor sensory axonal neuropathy (AMSAN), and some other variants like Miller-Fisher syndrome (MFS)."
"Patient with AMAN variant of GBS after severe bilateral pneumonia and ARDS due to the novel pandemic H1N1 influenza A virus is presented. 28-year-old white female was admitted to our Intensive Care Unit during the influenza pandemic because of severe ARDS due to bilateral pneumonia. The course of the disease was complicated with the new onset tetraplegia due to the AMAN variant of GBS. Treatment with plasma exchange was conducted and the patient had satisfactory recovery. We report a case of AMAN variant of GBS associated with proven H1N1 influenza A infection. This virus has not been reported previously as the agent of antecedent infection that induced this disorder. Risk factors for other causes of ICU neuromuscular weakness are usually present in the ICU patients and should not be the reason for reluctance in active quest for GBS," wrote M. Kutlesa and colleagues, University Hospital (see also Pandemics).
The researchers concluded: "Once the diagnosis of GBS is established or suspected the treatment with plasma exchange or intravenous immune globulin is indicated."
Kutlesa and colleagues published their study in Neurocritical Care (Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocritical Care, 2010;13(1):98-100).
For more information, contact M. Kutlesa, University Hospital for Infectious Diseases Dr. Fran Mihaljevic, Dept. of Neuroinfections and Intensive Care Medicine, Mirogojska 8, HR-10000, Zagreb, Croatia.
Publisher contact information for the journal Neurocritical Care is: Springer, 233 Spring Street, New York, NY 10013, USA.
http://insurancenewsnet.com/article.aspx?id=209191&type=newswires
"Patient with AMAN variant of GBS after severe bilateral pneumonia and ARDS due to the novel pandemic H1N1 influenza A virus is presented. 28-year-old white female was admitted to our Intensive Care Unit during the influenza pandemic because of severe ARDS due to bilateral pneumonia. The course of the disease was complicated with the new onset tetraplegia due to the AMAN variant of GBS. Treatment with plasma exchange was conducted and the patient had satisfactory recovery. We report a case of AMAN variant of GBS associated with proven H1N1 influenza A infection. This virus has not been reported previously as the agent of antecedent infection that induced this disorder. Risk factors for other causes of ICU neuromuscular weakness are usually present in the ICU patients and should not be the reason for reluctance in active quest for GBS," wrote M. Kutlesa and colleagues, University Hospital (see also Pandemics).
The researchers concluded: "Once the diagnosis of GBS is established or suspected the treatment with plasma exchange or intravenous immune globulin is indicated."
Kutlesa and colleagues published their study in Neurocritical Care (Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection. Neurocritical Care, 2010;13(1):98-100).
For more information, contact M. Kutlesa, University Hospital for Infectious Diseases Dr. Fran Mihaljevic, Dept. of Neuroinfections and Intensive Care Medicine, Mirogojska 8, HR-10000, Zagreb, Croatia.
Publisher contact information for the journal Neurocritical Care is: Springer, 233 Spring Street, New York, NY 10013, USA.
http://insurancenewsnet.com/article.aspx?id=209191&type=newswires